Medicis Pharmaceutical Corp. (MRX) Reports In-Line Q2 EPS of 64c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $71.88 +0.60%
Financial Fact:
Cost of product revenues (1): 19.6M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Cost of product revenues (1): 19.6M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q2 EPS of $0.64, in-line with the analyst estimate of $0.64. Revenue for the quarter came in at $190.8 million versus the consensus estimate of $188.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marex Group PLC (MRX) PT Raised to $90 at Keefe, Bruyette & Woods
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Marex Group PLC (MRX) PT Raised to $86 at Barclays
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
